NMTC NeuroOne Medical Technologies Corporation
Healthcare$3.87+4.88%ClosedMarket Cap: $33.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
5.79
P/S
3.27
EV/EBITDA
-4.38
DCF Value
$-286.62
FCF Yield
-23.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
54.5%
Operating Margin
-72.7%
Net Margin
-68.3%
ROE
-98.3%
ROA
-84.5%
ROIC
-112.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 null | $2.4M | 53.8% | $-2.1M | $-2.1M | $— | — |
| Q1 null | $2.9M | 54.2% | $-1.7M | $-1.4M | $— | — |
| Q4 null | $2.7M | 55.8% | $-1.4M | $-1.6M | $— | — |
| FY null | $12.1M | 67.3% | $-4.2M | $-3.6M | $— | — |
| Q3 null | $1.7M | 53.9% | $-1.9M | $-1.5M | $— | — |
| Q2 null | $1.4M | 55.6% | $-2.7M | $-2.3M | $— | — |
| Q1 null | $3.3M | 58.9% | $1.7M | $1.8M | $— | — |
| Q4 null | $272.3K | 51.8% | $-2.8M | $-3.4M | $— | — |
| FY null | $3.5M | 31.3% | $-11.9M | $-12.3M | $— | — |
| Q3 null | $825.8K | 34.1% | $-2.8M | $-2.8M | $— | — |
| Q2 null | $1.4M | 28.3% | $-2.9M | $-2.9M | $— | — |
| Q1 2024 | $977.6K | 27.2% | $-3.4M | $-3.3M | $-0.14 | — |